Zeria Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceutical products. It operates through the following segments: Medical Pharmaceuticals and Consumer Healthcare. The Medical Pharmaceuticals segment deals with the research, development, and distribution of medical drugs. The Consumer Healthcare segment manufactures, supplies, and markets self-medication over-the-counter (OTC) drugs, health foods, quasi drugs, and cosmetics. The company was founded in December 22, 1955 and is headquartered in Tokyo, Japan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company